相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer
Hidenori Takahashi et al.
ANNALS OF SURGERY (2012)
Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer
Akimasa Nakao et al.
ANNALS OF SURGERY (2012)
Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
Jayme B. Stokes et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Neoadjuvant GTX Chemotherapy and IMRT-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
Manish Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials
M. Mura Assifi et al.
SURGERY (2011)
Serum CA19-9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival
Hidenori Takahashi et al.
ANNALS OF SURGERY (2010)
Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy
Douglas B. Evans et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
Yun Shin Chun et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer
Rebecca J. McClaine et al.
HPB (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer
Hiroaki Ohigashi et al.
ANNALS OF SURGERY (2009)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
S-1: a promising new oral fluoropyrimidine derivative
Muhammad Wasif Saif et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma The French Phase II FFCD 9704-SFRO Trial
Romuald Le Scodan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma
Kimberly M. Brown et al.
AMERICAN JOURNAL OF SURGERY (2008)
Neoadjuvant treatment for pancreatic cancer - A review
Regina V. Tse et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R. Varadhachary et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B. Evans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A late phase II study of S-1 for metastatic pancreatic cancer
Takuji Okusaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Delayed gastric emptying (DGE) after pancreatic surgery:: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Moritz N. Wente et al.
SURGERY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma
MS Talamonti et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Postoperative pancreatic fistula: An international study group (ISGPF) definition
C Bassi et al.
SURGERY (2005)
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
RR White et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma
V Moutardier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)